Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Aug 1;206(3):421-30.
doi: 10.1093/infdis/jis360. Epub 2012 May 21.

Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults

Patricia M Flynn  1 , Sharon Nachman, Petronella Muresan, Terence Fenton, Stephen A Spector, Coleen K Cunningham, Robert Pass, Ram Yogev, Sandra Burchett, Barbara Heckman, Anthony Bloom, L Jill Utech, Patricia Anthony, Elizabeth Petzold, Wende Levy, George K Siberry, Ruth Ebiasah, Judi Miller, Edward Handelsman, Adriana Weinberg; IMPAACT P1088 Team
Affiliations

Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults

Patricia M Flynn et al. J Infect Dis. .

Erratum in

  • J Infect Dis. 2012 Dec 15;206(12):1951

Abstract

Background: The safety and immunogenicity of high-dose pandemic H1N1 (pH1N1) vaccination in perinatally human immunodeficiency virus type 1 (HIV-1)-infected children, adolescents, and young adults are unknown.

Methods: Two 30-μg doses of 2009 Novartis pH1N1 monovalent vaccine (Fluvirin) were administered 21-28 days apart to perinatally HIV-1-infected children, adolescents, and young adults. Antibodies were measured by hemagglutination inhibition (HAI) assay at baseline, 21-28 days after first vaccination, 7-13 days after the second vaccination, and 7 months after the first vaccination.

Results: Among the 155 participants, 54 were aged 4-8 years, 51 were aged 9-17 years, and 50 were aged 18-24 years. After 2 doses of Fluvirin, seroresponse (≥ 4-fold rise in HAI titers) was demonstrated in 79.6%, 84.8%, and 83% of participants in the aforementioned age groups, respectively, and seroprotection (HAI titers ≥ 40) was shown in 79.6%, 82.6%, and 85.1%, respectively. Of those lacking seroresponse (n = 43) or seroprotection (n = 37) after the first vaccination, 46.5% and 40.5% achieved seroresponse or seroprotection, respectively, after the second vaccination. Among participants who lacked seroprotection at entry, a "complete response" (both seroresponse and seroprotection) after first vaccination was associated with higher baseline log(10) HAI titer and non-Hispanic ethnicity. No serious vaccine-related events occurred.

Conclusion: Two doses of double-strength pH1N1 vaccine are safe and immunogenic and may provide improved protection against influenza in perinatally HIV-1-infected children and youth.

Clinical trials registration: NCT00992836.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Patient flowchart after enrollment. Abbreviations: ARVs, antiretrovirals; HAI, hemagglutination inhibition titers.
Figure 2.
Figure 2.
Geometric mean and 95% confidence interval (CI) hemagglutination inhibition (HAI) titers among vaccine recipients by age group.
See this image and copyright information in PMC

References

    1. Dawood FS, Jain S, Finelli L, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605–15. - PubMed
    1. Peiris JS, Poon LL, Guan Y. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol. 2009;45:169–73. - PMC - PubMed
    1. Gatherer D. The 2009 H1N1 influenza outbreak in its historical context. J Clin Virol. 2009;45:174–8. - PubMed
    1. World Health Organization. Global Alert and Response: Situation Updates (Pandemic) H1N1 2009. http://www.who.int/csr/disease/swineflu/updates/en/index.html. Accessed May 29, 2012.
    1. Bautista E, Chotpitayasunondh T, Gao Z, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med. 2010;362:1708–19. - PubMed

Publication types

Associated data